Rohto Pharmaceutical Statistics Share Statistics Rohto Pharmaceutical has 228.14M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 228.14M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 171.73M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios The PE ratio is 22.91 and the forward
PE ratio is null.
Rohto Pharmaceutical's PEG ratio is
0.
PE Ratio 22.91 Forward PE n/a PS Ratio 2.62 Forward PS n/a PB Ratio 2.88 P/FCF Ratio 27.98 PEG Ratio 0
Financial Ratio History Enterprise Valuation Rohto Pharmaceutical has an Enterprise Value (EV) of 630.14B.
EV / Sales 2.33 EV / EBITDA 12.5 EV / EBIT 18.4 EV / FCF 24.87
Financial Position The company has a current ratio of 2.47,
with a Debt / Equity ratio of 0.04.
Current Ratio 2.47 Quick Ratio 1.93 Debt / Equity 0.04 Debt / EBITDA 0.21 Debt / FCF 0.41 Interest Coverage 204.33
Financial Efficiency Return on Equity is 12.56% and Return on Invested Capital is 11.45%.
Return on Equity 12.56% Return on Assets 8.94% Return on Invested Capital 11.45% Revenue Per Employee $37.31M Profits Per Employee $4.26M Employee Count 7,259 Asset Turnover 0.78 Inventory Turnover 2.43
Taxes Income Tax 10.12B Effective Tax Rate 24.38%
Stock Price Statistics The stock price has increased by -1.95% in the
last 52 weeks. The beta is -0.35, so Rohto Pharmaceutical's
price volatility has been lower than the market average.
Beta -0.35 52-Week Price Change -1.95% 50-Day Moving Average 20.61 200-Day Moving Average 20.97 Relative Strength Index (RSI) 0.03 Average Volume (20 Days) 93
Income Statement In the last 12 months, Rohto Pharmaceutical had revenue of 270.84B
and earned 30.94B
in profits. Earnings per share was 135.6.
Revenue 270.84B Gross Profit 157.29B Operating Income 40.05B Net Income 30.94B EBITDA 50.4B EBIT 41.71B Earnings Per Share (EPS) 135.6
Full Income Statement Balance Sheet The company has 89.21B in cash and 10.49B in
debt, giving a net cash position of 78.72B.
Cash & Cash Equivalents 89.21B Total Debt 10.49B Net Cash 78.72B Retained Earnings 209.4B Total Assets 346.18B Working Capital 127.67B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 34.24B
and capital expenditures -8.91B, giving a free cash flow of 25.33B.
Operating Cash Flow 34.24B Capital Expenditures -8.91B Free Cash Flow 25.33B FCF Per Share 111.04
Full Cash Flow Statement Margins Gross margin is 58.07%, with operating and profit margins of 14.79% and 11.42%.
Gross Margin 58.07% Operating Margin 14.79% Pretax Margin 15.33% Profit Margin 11.42% EBITDA Margin 18.61% EBIT Margin 14.79% FCF Margin 9.35%
Dividends & Yields RPHCF pays an annual dividend of $0.21,
which amounts to a dividend yield of 0.56%.
Dividend Per Share $0.21 Dividend Yield 0.56% Dividend Growth (YoY) -99.04% Payout Ratio 24.64% Earnings Yield 4.36% FCF Yield 3.57%
Dividend Details Analyst Forecast Currently there are no analyst rating for RPHCF.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 29, 2022. It was a
forward
split with a ratio of 2:1.
Last Split Date Dec 29, 2022 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 1.92 Piotroski F-Score 6
